Join
Live feed
·
INSIDERFilingvia Quantisnow
Alimera Sciences Inc. logo

SEC Form 3: Ocumension Therapeutics claimed ownership of 1,144,945 units of Common Stock

ByQuantisnow·Wall Street's wire, on your screen.
ALIM· Alimera Sciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALIM (Alimera Sciences Inc.) and more on Quantisnow.